Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.

Author(s): Jogi R, Garman M, Pielop J, Orengo I, Hsu S

Affiliation(s): Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA.

Publication date & source: 2005-09, J Drugs Dermatol., 4(5):652-6.

Publication type: Case Reports

Although cutaneous reactions from antineoplastic therapy are common, a reticulate pattern of hyperpigmentation has not been frequently reported in the literature. We report 2 cases of reticulate hyperpigmentation associated with cancer chemotherapy with 5-fluorouracil and idarubicin. These 2 cases serve to raise awareness of this particular pattern of hyperpigmentation as a potential side effect of chemotherapeutic regimens.